Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-305-4 | CAS number: 24544-04-5
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: non-GLP study performed in accordance with the corresponding OECD-/EU-testing guidelines
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- other: Salmonella typhimurium TA1535, TA1537, TA1538, TA98 and TA100
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Dr. Bruce Ames, Univ.of California, Berkeley, Ca.
- Properly maintained: yes - Additional strain / cell type characteristics:
- DNA polymerase A deficient
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-liver fractions of rats induced with Aroclor 1254
- Test concentrations with justification for top dose:
- 1 ul; 0.3 ul; 0.1 ul; 0.03 ul; 0.01 ul/p!ate in the absence and presence of exogenous metabolic activation
- Vehicle / solvent:
- Sectrophotometric grade dimethylsulfoxide (DMSO, CAS 67-68-5); Lot KHML, obtained from Mallinckrodt Chemical Company, St. Louis, Mo. Dilutions were made on the day required.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- other: 2-aminoanthracene
- Evaluation criteria:
- The numbers of revertant colonies from each set of triplicate plates were averaged and the standard deviation calculated. The average number of revertant colonies found in the test compound plates was compared to that found with the solvent control. A compound is considered a mutagen if a dose related increase in the number of revertant colonies is found in the treatment groups. The first dose level considered for the increase must have an average number of revertant colonies which is three times that of the solvent control.
- Species / strain:
- other: Salmonella typhimurium TA1535, TA1537, TA1538, TA98 and TA100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The negative controls, positive controls, and sterility controls all fulfilled requirements for determination of a valid test.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
No detectable mutagenic activity was found for test article T1567 when the Salmonella/microsomal assay was performed - Executive summary:
This reverse mutation assay was performed in 1980 in accordance with OECD-guidelines without GLP. Five Salm. typh. strains (TA1535, TA1537, TA1538, TA98 and TA100) were tested with and without metabolic activation. Test concentrations ranged from 0.01 ug/plate up to 1 ug/plate.
No detectable mutagenic activity was found for test article T1567 when the Salmonella/microsomal assay was performed
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for selection of genetic toxicity endpoint
non-GLP; Klimisch 2
Justification for classification or non-classification
Based on the data available the substance is not classified or labeled according to Directive 67/548/EEC (DSD) or Regulation 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
